-
MRNS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Marinus Pharmaceuticals (MRNS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 42.18 mm | 42.18 mm | 42.18 mm | 42.18 mm | 42.18 mm | 42.18 mm |
Cash burn (monthly) | 7.50 mm | 8.19 mm | 8.07 mm | 11.71 mm | 6.48 mm | 9.56 mm |
Cash used (since last report) | 38.09 mm | 41.60 mm | 41.03 mm | 59.49 mm | 32.95 mm | 48.59 mm |
Cash remaining | 4.09 mm | 581.45 k | 1.15 mm | -17.30 mm | 9.24 mm | -6.40 mm |
Runway (months of cash) | 0.5 | 0.1 | 0.1 | -1.5 | 1.4 | -0.7 |
13F holders | Current |
---|---|
Total holders | 79 |
Opened positions | 14 |
Closed positions | 26 |
Increased positions | 20 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 69.90 bn |
Total shares | 48.94 mm |
Total puts | 75.50 k |
Total calls | 172.90 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Suvretta Capital Management | 5.07 mm | $8.93 bn |
BEN Franklin Resources | 4.71 mm | $8.48 bn |
Tang Capital Management | 4.70 mm | $8.27 bn |
Tang Capital Partners | 4.50 mm | $5.40 mm |
Sofinnova Investments | 4.39 mm | $7.72 bn |
Vanguard | 2.80 mm | $4.93 bn |
Bain Capital Life Sciences Investors | 2.69 mm | $4.74 bn |
Standard Life Aberdeen | 2.66 mm | $4.68 bn |
Bleichroeder | 1.87 mm | $3.30 bn |
BlackRock | 1.86 mm | $3.27 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Feb 25 | Silverstein Christine Berni | Common Stock | Sale back to company | Dispose D | No | No | 0.55 | 4,702 | 2.59 k | 0 |
11 Feb 25 | Silverstein Christine Berni | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.94 | 32,400 | 192.46 k | 0 |
11 Feb 25 | Silverstein Christine Berni | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.74 | 20,900 | 203.57 k | 0 |
11 Feb 25 | Silverstein Christine Berni | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.4 | 10,450 | 14.63 k | 0 |
11 Feb 25 | Steven Pfanstiel | Common Stock | Sale back to company | Dispose D | No | No | 0.55 | 62,470 | 34.36 k | 0 |
11 Feb 25 | Steven Pfanstiel | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.99 | 220,000 | 3.08 mm | 0 |
11 Feb 25 | Steven Pfanstiel | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.4 | 74,475 | 774.54 k | 0 |
11 Feb 25 | Steven Pfanstiel | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.94 | 126,585 | 751.91 k | 0 |
11 Feb 25 | Steven Pfanstiel | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.74 | 114,600 | 1.12 mm | 0 |
11 Feb 25 | Steven Pfanstiel | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.4 | 57,300 | 80.22 k | 0 |